Brief: Herantis Pharma H1 operating loss narrows to 2.6 million euros

Herantis Pharma Oyj

25/08/2016 07:06

Aug 25 (Reuters) - Herantis Pharma Oyj  HRTIS.HE : 
    * H1 revenue 25,291 euros versus 1,155 euros year ago 
    * H1 operating loss 2.6 million euros ($2.9 million) versus 
loss 13.7 million euros 
 
Source text for Eikon:  ID:nGNE8lpzrT  
     
Further company coverage:  HRTIS.HE  
 
($1 = 0.8872 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))